智通财经APP讯，永胜医疗(01612)发布截至2025年6月30日止6个月的中期业绩，该集团取得收入4.49亿港元，同比增加18.05%;公司拥有人应占溢利5162.9万港元，同比增加55.1%;基本每股盈利8.03港仙。
2025年上半年表现强劲主要受成像一次性产品分部所得收入上升28.6%所带动。
呼吸产品分部的收入回复增长，幅度更足以抵销有余来自骨科支护复康器具分部贡献的减少。
在规模经济效益扩大、营运效率提升及存货拨备减少的因素支持下，毛利增加33.4%至1.59亿港元。毛利率由31.3%改善至35.4%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.